Homatropine
Clinical data | |
---|---|
AHFS/Drugs.com | Monograph |
MedlinePlus | a601006 |
ATC code | A02BX03 (WHO) S01FA05 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 87-00-3 |
PubChem (CID) | 6321423 |
DrugBank | DB00725 |
ChemSpider | 16498795 |
UNII | 8QS6WCL55Z |
ChEMBL | CHEMBL1233442 |
ECHA InfoCard | 100.001.561 |
Chemical and physical data | |
Formula | C16H21NO3 |
Molar mass | 356.26 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Homatropine (Equipin, Isopto Homatropine) is an anticholinergic medication that is an antagonist at muscarinic acetylcholine receptors and thus the parasympathetic nervous system. It is used in eye drops as a cycloplegic (to temporarily paralyze accommodation), and as a mydriatic (to dilate the pupil). For Homatropine methylbromide see Methylhomatropine, this is a different medication. Homatropine is less potent than atropine and has a shorter duration of action. It is available as the hydrobromide salt.
Homatropine is also given as an atropine substitute given to reverse the muscarinic and CNS effects associated with indirect cholinomimetic (anti-AChase) administration.
Side effects
- Blurred vision
- Sensitivity to light
Contraindications
- Untreated glaucoma
- Myasthenia gravis
- Severe heart failure
- Thyrotoxicosis
References
This article is issued from Wikipedia - version of the 9/4/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.